Align Technology, Inc. (ALGN)
NASDAQ: ALGN · Real-Time Price · USD
136.00
+0.42 (0.31%)
At close: Oct 23, 2025, 4:00 PM EDT
136.03
+0.03 (0.02%)
After-hours: Oct 23, 2025, 6:11 PM EDT
Align Technology Market Cap
Align Technology has a market cap or net worth of $9.86 billion as of October 23, 2025. Its market cap has decreased by -43.80% in one year.
Market Cap
9.86B
Enterprise Value
9.16B
1-Year Change
-43.80%
Ranking
Category
Stock Price
$136.00
Market Cap Chart
Since January 30, 2001, Align Technology's market cap has increased from $769.80M to $9.86B, an increase of 1,180.61%. That is a compound annual growth rate of 10.86%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 22, 2025 | 9.83B | -36.86% |
Dec 31, 2024 | 15.57B | -25.83% |
Dec 29, 2023 | 20.99B | 27.39% |
Dec 30, 2022 | 16.47B | -68.21% |
Dec 31, 2021 | 51.82B | 22.98% |
Dec 31, 2020 | 42.14B | 91.60% |
Dec 31, 2019 | 21.99B | 31.29% |
Dec 31, 2018 | 16.75B | -5.97% |
Dec 29, 2017 | 17.81B | 132.55% |
Dec 30, 2016 | 7.66B | 46.35% |
Dec 31, 2015 | 5.23B | 16.61% |
Dec 31, 2014 | 4.49B | -2.19% |
Dec 31, 2013 | 4.59B | 103.21% |
Dec 31, 2012 | 2.26B | 21.17% |
Dec 30, 2011 | 1.86B | 25.00% |
Dec 31, 2010 | 1.49B | 12.37% |
Dec 31, 2009 | 1.33B | 126.20% |
Dec 31, 2008 | 586.60M | -48.68% |
Dec 31, 2007 | 1.14B | 27.70% |
Dec 29, 2006 | 895.10M | 122.94% |
Dec 30, 2005 | 401.50M | -38.40% |
Dec 31, 2004 | 651.80M | -32.58% |
Dec 31, 2003 | 966.80M | 628.01% |
Dec 31, 2002 | 132.80M | -38.40% |
Dec 31, 2001 | 215.60M | -71.99% |
View and export this data all the way back to 2001. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 717.80B |
Johnson & Johnson | 462.11B |
AbbVie | 408.76B |
UnitedHealth Group | 330.91B |
AstraZeneca | 259.08B |
Novartis AG | 254.74B |
Novo Nordisk | 249.65B |
Abbott Laboratories | 221.98B |